Citius Oncology Inc (CTOR)

$2.23 +0.36 (19.25%)
Market Cap 154.39M
Revenue (ttm) 0.00
Net Income (ttm) -21.15M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.25
Volume 1,166,583
Avg Vol 2,278,746
Day's Range N/A - N/A
Shares Out 78.37M
Stochastic %K 35%
Beta 3.06
Analysts Hold
Price Target $3.00

Company Profile

Citius Oncology, Inc. focuses on the development of novel targeted oncology therapies. It also engages in the development of LYMPHIR, an orphan indication for the treatment of adults with relapsed or refractory cutaneous T-cell lymphoma. The company is headquartered in New York, New York. Citius Oncology, Inc. operates as a subsidiary of Citius Pharmaceuticals, Inc.

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 347-627-0058
Address:
420 Lexington Avenue, Suite 2446, New York, United States
donein12
donein12 Jul. 29 at 5:36 PM
$CTOR Just a thought. I am hoping some of this volume is applicabe to institutions that are allowed to buy stocks under $5.
0 · Reply
UNTR8ABLE
UNTR8ABLE Jul. 29 at 5:23 PM
$RCON $CTOR
0 · Reply
Drainomight
Drainomight Jul. 29 at 5:04 PM
$CTOR after hours might get interesting
0 · Reply
Lwschadler
Lwschadler Jul. 29 at 5:00 PM
$CTOR Climb!
0 · Reply
Gemola
Gemola Jul. 29 at 4:20 PM
$CTOR First target $2.65 boolish
0 · Reply
OkieDokieTrader
OkieDokieTrader Jul. 29 at 4:03 PM
@Stock_Catcher $CTOR Big dog has some bite at this level.
0 · Reply
raoul100
raoul100 Jul. 29 at 3:03 PM
$CTOR baby wants to break out!!!
0 · Reply
BigSqueezeComing
BigSqueezeComing Jul. 29 at 2:47 PM
$CTOR PT 2.5
1 · Reply
Benjamin2020
Benjamin2020 Jul. 29 at 1:52 PM
$CTOR when $5?!?
1 · Reply
Drainomight
Drainomight Jul. 29 at 11:57 AM
$CTOR
0 · Reply
Latest News on CTOR
Citius Oncology Announces Closing of $9.0 Million Public Offering

Jul 17, 2025, 4:30 PM EDT - 11 days ago

Citius Oncology Announces Closing of $9.0 Million Public Offering

CTXR

Citius Oncology Announces Pricing of $9.0 Million Public Offering

Jul 16, 2025, 9:15 AM EDT - 13 days ago

Citius Oncology Announces Pricing of $9.0 Million Public Offering

CTXR

Citius Oncology Expands Distribution Network for LYMPHIR with Execution of Distribution Services Agreement with Cencora

Jul 15, 2025, 8:32 AM EDT - 14 days ago

Citius Oncology Expands Distribution Network for LYMPHIR with Execution of Distribution Services Agreement with Cencora

CTXR

Citius Oncology Anticipates Commercial Launch of LYMPHIR™ in 2025

Jun 17, 2025, 8:08 AM EDT - 6 weeks ago

Citius Oncology Anticipates Commercial Launch of LYMPHIR™ in 2025

CTXR

Citius Oncology, Inc. Reports Fiscal Second Quarter 2025 Financial Results and Provides Business Update

May 14, 2025, 4:30 PM EDT - 2 months ago

Citius Oncology, Inc. Reports Fiscal Second Quarter 2025 Financial Results and Provides Business Update

Citius Pharmaceuticals to Present at the Jefferies Global Healthcare Conference

May 5, 2025, 8:37 AM EDT - 3 months ago

Citius Pharmaceuticals to Present at the Jefferies Global Healthcare Conference

CTXR

Citius Pharmaceuticals, Inc. Reports Fiscal First Quarter 2025 Financial Results and Provides Business Update

Feb 14, 2025, 4:30 PM EST - 5 months ago

Citius Pharmaceuticals, Inc. Reports Fiscal First Quarter 2025 Financial Results and Provides Business Update

CTXR

Citius Oncology, Inc. Reports Fiscal First Quarter 2025 Financial Results and Provides Business Update

Feb 14, 2025, 4:30 PM EST - 5 months ago

Citius Oncology, Inc. Reports Fiscal First Quarter 2025 Financial Results and Provides Business Update

Citius Pharmaceuticals and Citius Oncology Announce Unique Permanent J-Code Issued for LYMPHIR by Centers for Medicare and Medicaid Services

Feb 6, 2025, 8:55 AM EST - 6 months ago

Citius Pharmaceuticals and Citius Oncology Announce Unique Permanent J-Code Issued for LYMPHIR by Centers for Medicare and Medicaid Services

CTXR

Citius Pharmaceuticals and Citius Oncology Highlight LYMPHIR Commercial Launch Planned for the First Half of 2025

Jan 7, 2025, 8:08 AM EST - 7 months ago

Citius Pharmaceuticals and Citius Oncology Highlight LYMPHIR Commercial Launch Planned for the First Half of 2025

CTXR

Citius Oncology Engages Jefferies as Exclusive Financial Advisor to Explore Strategic Alternatives

Jan 6, 2025, 7:50 AM EST - 7 months ago

Citius Oncology Engages Jefferies as Exclusive Financial Advisor to Explore Strategic Alternatives

CTXR

Citius Oncology, Inc. Reports Fiscal Full Year 2024 Financial Results and Provides Business Update

Dec 27, 2024, 5:00 PM EST - 7 months ago

Citius Oncology, Inc. Reports Fiscal Full Year 2024 Financial Results and Provides Business Update

donein12
donein12 Jul. 29 at 5:36 PM
$CTOR Just a thought. I am hoping some of this volume is applicabe to institutions that are allowed to buy stocks under $5.
0 · Reply
UNTR8ABLE
UNTR8ABLE Jul. 29 at 5:23 PM
$RCON $CTOR
0 · Reply
Drainomight
Drainomight Jul. 29 at 5:04 PM
$CTOR after hours might get interesting
0 · Reply
Lwschadler
Lwschadler Jul. 29 at 5:00 PM
$CTOR Climb!
0 · Reply
Gemola
Gemola Jul. 29 at 4:20 PM
$CTOR First target $2.65 boolish
0 · Reply
OkieDokieTrader
OkieDokieTrader Jul. 29 at 4:03 PM
@Stock_Catcher $CTOR Big dog has some bite at this level.
0 · Reply
raoul100
raoul100 Jul. 29 at 3:03 PM
$CTOR baby wants to break out!!!
0 · Reply
BigSqueezeComing
BigSqueezeComing Jul. 29 at 2:47 PM
$CTOR PT 2.5
1 · Reply
Benjamin2020
Benjamin2020 Jul. 29 at 1:52 PM
$CTOR when $5?!?
1 · Reply
Drainomight
Drainomight Jul. 29 at 11:57 AM
$CTOR
0 · Reply
BullishNews
BullishNews Jul. 28 at 1:45 PM
$SMX $MGRT $TRON $CTOR $TRUG
0 · Reply
_www_larval_com_
_www_larval_com_ Jul. 28 at 1:43 PM
$SMX 10%[44%] $MGRT 7%[-19%] $TRON 6%[23%] $CTOR -6%[-8%] $TRUG -6%[10%] most notable movement within the first minutes of trading.
0 · Reply
chrisnyc578
chrisnyc578 Jul. 27 at 9:55 PM
$CTOR @TwongStocks Do you still believe in Jeffries finding a deal?
1 · Reply
Bulltrader988
Bulltrader988 Jul. 26 at 7:03 PM
$CTXR ownership of $CTOR is now 84.3 % because of the newest offering from $CTOR 👃👀 https://www.sec.gov/Archives/edgar/data/1506251/000121390025067797/xslSCHEDULE_13D_X01/primary_doc.xml
0 · Reply
Cheriebomb
Cheriebomb Jul. 26 at 4:57 PM
$CTOR Great time to buy. I didn't think we'd see under 2$ again.
0 · Reply
swagmastersupreme
swagmastersupreme Jul. 26 at 3:09 PM
$CTOR this keeps pushing up over $2 most days and wants to surge. Do we have any upcoming catalysts about Lymphir? When it launches this will go up. Late end of 2025 is the earliest this could come on optimistically
0 · Reply
TwongStocks
TwongStocks Jul. 25 at 9:04 PM
New 13D filing updates $CTXR ownership stake in $CTOR https://www.sec.gov/Archives/edgar/data/1506251/000121390025067797/xslSCHEDULE_13D_X01/primary_doc.xml After CTOR's recent offering, CTXR now owns 84.3% of CTOR. Down from 92.3% 78,370,402 outstanding shares of CTOR. CTXR owns 66,049,615.
3 · Reply
bullish51892
bullish51892 Jul. 25 at 6:55 PM
$YHC $CTOR Looking juicy for Monday if they hold up today.
0 · Reply
Perillo1983
Perillo1983 Jul. 25 at 4:43 PM
$CTOR Getting all their ducks in a row$$$$$$$
1 · Reply
BALUGA825
BALUGA825 Jul. 25 at 4:09 PM
$CTXR $CTOR Staying green as much as possible today is the objective and we enter bulls territory next week. History tends to repeat itself! Back track chart for few weeks and you will see what i am up to.
0 · Reply
DrKyle
DrKyle Jul. 25 at 3:15 PM
$CTOR $CTXR i rest re-entered ctxr and took my entry position in ctor. I held ctxr with mino-lok being the most attractive at the time. Granted my plan didnt go well at the time as all longs recall. My question is in regards to ctxr owning 92% of CTOR and the market caps respectively of each....what am i missing here....?? Thanks
1 · Reply
Gemola
Gemola Jul. 25 at 2:45 PM
$CTOR First target $2.75 - $3.50 boolish
0 · Reply